# A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)

> **NCT01603043** · PHASE2 · TERMINATED · sponsor: **Alcon Research** · enrollment: 10 (actual)

## Conditions studied

- Geographic Atrophy

## Interventions

- **DRUG:** Al-78898A
- **DRUG:** Sham injection

## Key facts

- **NCT ID:** NCT01603043
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Management Decision
- **Last updated:** 2014-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603043, "A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01603043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*